Hormonal health

Nonclassic CAH: The PCOS Look-Alike Few Test For

Save

Nonclassic congenital adrenal hyperplasia is an inherited enzyme condition that raises adrenal androgens and closely mimics PCOS. Because acne, irregular periods, and extra hair overlap, it can be mistaken for PCOS unless a morning 17-hydroxyprogesterone blood test is checked. Guidelines suggest considering it when androgen excess is evaluated.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What is nonclassic congenital adrenal hyperplasia?

Nonclassic congenital adrenal hyperplasia is a milder, later-appearing form of an inherited group of enzyme conditions affecting the adrenal glands 1. In more than 9 in 10 cases the affected enzyme is 21-hydroxylase, which the adrenal glands need to make cortisol efficiently 1. When its activity is only partly reduced, the glands compensate in a way that raises androgen output, producing symptoms in the teens or twenties rather than at birth 1. Symptoms typically emerge between the ages of 10 and 25 rather than in infancy, which is what earns it the label late-onset 1. Because the changes are gradual, they are easy to attribute to more common causes. That overlap is exactly why guidelines fold NCAH screening into the wider evaluation of androgen excess, according to Endocrine Society hirsutism guidance 1.

How is NCAH different from PCOS?

NCAH and PCOS can look almost identical from the outside, which is the core of the problem. Both cause acne, scalp hair thinning, unwanted facial or body hair, and irregular periods, and both often appear in adolescence 2. The difference lies underneath: PCOS is driven mainly by the ovaries and insulin dynamics, while NCAH stems from an inherited adrenal enzyme difference 3. Because polycystic ovary syndrome affects roughly 1 in 10 women and NCAH far fewer, PCOS is diagnosed far more often, and NCAH can be missed 2. Comparing the two next to a clear list of PCOS symptoms helps frame why testing is what separates them 3.

How is NCAH diagnosed?

A single early-morning 17-hydroxyprogesterone blood test is the usual screening step for NCAH 1. When that value is elevated, a follow-up stimulation test can confirm the diagnosis, and genetic testing can clarify inheritance 1. Both the Endocrine Society and the 2023 international PCOS guideline advise considering this screen before settling on a PCOS label, precisely because treatments and family-planning implications differ 12. Timing matters, since 17-hydroxyprogesterone is highest in the first few hours after waking and varies across the 28-day cycle 1. Pairing the result with a broader hormonal panel, including a thyroid blood test, rounds out the picture 3.

Why does getting the diagnosis right matter as it runs in families?

Naming NCAH correctly changes counseling in ways a PCOS label does not. The condition is inherited in an autosomal recessive pattern, meaning a child receives an affected gene copy from each of 2 parents, so a diagnosis has implications for siblings and future pregnancies 3. Across the lifespan, symptoms often surface in adolescence as periods begin and can shift again through the reproductive years and toward the perimenopausal transition 2. Some people with NCAH have reduced fertility that responds to targeted treatment rather than standard PCOS approaches 3. For that reason, a confirmed diagnosis often prompts a conversation about testing siblings and, where relevant, a partner 3. Knowing which condition is present lets a specialist tailor both symptom care and family-planning conversations, according to ACOG guidance 3.

When to see a specialist

An endocrinologist or a gynecologist with hormonal expertise is well suited to sort NCAH from PCOS and to manage it. Because the screening test has timing quirks and the follow-up can involve a stimulation test or genetic testing, specialist input helps get the sequence right 1. A clinician can also connect the diagnosis to related concerns, from hormonal facial hair to fertility planning, and explain what it means for relatives 3. Roughly 1 in 4 people carry a single recessive gene change for the classic enzyme in some populations, so family testing is often discussed 3. Gale can help you organize your history and prior labs before that appointment.

Common questions

No. The classic form is severe and detected in infancy, while the nonclassic form is milder and appears later, often in the teens or twenties. They involve the same enzyme system but differ greatly in how much enzyme activity is lost and how they present.

PCOS is far more common, affecting roughly 1 in 10 women of reproductive age, while nonclassic CAH is found in a much smaller share of women evaluated for androgen excess. That imbalance is part of why NCAH is often overlooked.

An early-morning 17-hydroxyprogesterone blood test is the usual first step. If it is elevated, a stimulation test can confirm the diagnosis. Guidelines suggest considering this screen before concluding that symptoms are due to PCOS.

It can. Some people with NCAH have reduced fertility or specific considerations during pregnancy, and because it is inherited, it has implications for children. A specialist can explain testing for partners and options for family planning.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When androgen symptoms deserve a closer look

  • Acne, irregular periods, and unwanted hair growth that started in the teens or twenties is a reason to seek clinician evaluation for the underlying cause.
  • Symptoms labeled PCOS that have never been reassessed despite a strong family history is a reason to ask a clinician about further testing.
  • Rapidly worsening androgen symptoms such as a deepening voice are a reason to seek prompt clinician review.
  • Difficulty conceiving alongside androgen-excess symptoms is a reason to arrange specialist evaluation.

This article is general health education, not medical advice. Diagnosing nonclassic CAH and telling it apart from PCOS is a decision for an endocrinologist or gynecologist, based on testing and your personal and family history.

References

  1. 1.Martin KA, et al. (Endocrine Society) (2018). Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/jc.2018-00241NCAH as a cause of androgen excess, 21-hydroxylase deficiency, and early-morning 17-hydroxyprogesterone screening folded into the hirsutism and androgen-excess workup, with stimulation and genetic testing to confirm.
  2. 2.Teede HJ, Tay CT, Laven J, et al. (International PCOS guideline consortium) (2023). Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/clinem/dgad463Excluding NCAH before diagnosing PCOS, overlap of features in adolescence and across the reproductive years, and PCOS prevalence of roughly 1 in 10.
  3. 3.American College of Obstetricians and Gynecologists (2018). ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002656PCOS differential diagnosis including 21-hydroxylase-deficient nonclassic CAH, inheritance and family-planning implications, and specialist evaluation for androgen excess and reduced fertility.

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy